XM无法为美国居民提供服务。
O
O

Oerlikon

技术摘要

指标价值趋势
指标价值趋势
指标价值趋势
指标S3S2S1PR1R2R3

市场新闻

Swiss stocks - Factors to watch on November 5

Swiss stocks - Factors to watch on November 5 ZURICH/GDANSK, Nov 5 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday: COMPANY STATEMENTS ADECCO GROUP AG ADEN.S Reports 4% drop in Q3 sales. OC OERLIKON OERL.S Posts Q3 group sales at 580 million Swiss francs. BURCKHARDT COMPRESSION HOLDING AG BCHN.S Posts HY operating income of 51.7 million Swiss francs, up 15.2% yoy.
A
O
S

OC Oerlikon Corporation AG Pfaeffikon Expects Operational EBITDA Margin About 16% For FY 2024

BRIEF-OC Oerlikon Corporation AG Pfaeffikon Expects Operational EBITDA Margin About 16% For FY 2024 Nov 5 (Reuters) - OC Oerlikon Corporation AG Pfaeffikon OERL.S : OC OERLIKON CORPORATION AG PFAEFFIKON - UPDATING 2024 GUIDANCE: EXPECT OPERATIONAL EBITDA MARGIN ABOUT 16% OC OERLIKON CORPORATION AG PFAEFFIKON - Q3 GROUP SALES DOWN 5% YEAR-OVER-YEAR
O

OC Oerlikon Q3 Group Sales At CHF 580 Mln

BRIEF-OC Oerlikon Q3 Group Sales At CHF 580 Mln Nov 5 (Reuters) - OC OERLIKON CORPORATION AG PFAEFFIKON OERL.S : SEES 2024 ORGANIC SALES DOWN BY HIGH SINGLE DIGIT TO LOW TEENS PERCENTAGE, PREV DOWN HIGH SINGLE DIGIT SEES 2024 OP EBITDA MARGIN AT ABOUT 16%, PREV 15.5-16.0% FROM JAN 2025 MERGING HEADQUARTERS WITH THAT OF SURFACE SOLUTIONS DIVISION WI
O

Swiss stocks - Factors to watch on August 6

Swiss stocks - Factors to watch on August 6 ZURICH/GDANSK, Aug 6(Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday: NOVARTIS NOVN.S Novartis and Viatris VTRS.O were hit with a federal lawsuit in Maryland on Monday by the family of a woman whose tissue cells were taken from her body in the 1950s and used to fuel medical research and development.
A
N
O

Oerlikon Says 2024 Operational EBITDA Margin Raised To 15.5-16.0%

BRIEF-Oerlikon Says 2024 Operational EBITDA Margin Raised To 15.5-16.0% Aug 6 (Reuters) - OC Oerlikon Corporation AG Pfaeffikon OERL.S : RAISING 2024 GUIDANCE AFTER STRONG EXECUTION IN THE FIRST HALF; SEPARATION ON TRACK Q2 SALES CHF 616 MILLION VERSUS COMPANY-COMPILED CONSENSUS OF CHF 598 MILLION Q2 ORDER INTAKE CHF 651 MILLION VERSUS COMPANY-COMP
O

商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明